Your gut feeling is probably as accurate as a structured score like the Wells score for pulmonary embolism.
Quantitative estimates of the likelihood of pulmonary embolus (PE) are commonly used in research protocols and have infiltrated routine practice in many settings. But are these structured scores better than a physician's judgment? Investigators reviewed data for 1038 French and Belgian patients who had been included in a prospective cohort study of suspected PE.
In the original prospective study, emergency physicians (including physicians in training) had recorded their gestalt impression of the likelihood of PE (low, moderate, or high) as well as clinical variables. In the current study, researchers retrospectively calculated the Wells score and the revised Geneva score, and compared them to the physicians' gestalt.
Clinical judgment outperf…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals